Lesion-Based Radiotherapy of the Ears, Lips and Eyelids for Skin Cancer
International Journal of Radiology & Radiation Therapy Case Series Open Access Lesion-based radiotherapy of the ears, lips and eyelids for skin cancer Abstract Volume 8 Issue 1 - 2021 Purpose: This study is a retrospective audit of radiotherapy (RT) for skin cancer of the ear, Anthony Tanous,1 David Tighe,1 Julie Bartley,2 eyelid, and lip in Sydney, Australia. The growth of referrals to a tertiary radiation oncology 3 4 service over a specific time period were also assessed. Gavin Gottschalk, Tanya Gilmour, Nicholas Lotz,5 Gerald B. Fogarty2 Materials and methods: The records of patients who received RT to the external ear, 1Faculty of Medicine, University of New South Wales, Australia eyelid or lip between January 1 2007 and April 30 2020 were reviewed. Patient, tumour, 2Genesis Care, Mater Hospital, Australia treatment and outcome factors were recorded. 3Chatswood Dermatology Centre, Australia 4North Shore Dermatology & Specialist Skin Cancer Centre, Results: 147 patients with a mean age of 73 years (range: 33-96) were identified as eligible Australia for inclusion. 165 lesions were treated and 18 patients had multiple treatment events. Of 5North Shore Cosmetic Surgery, Level 1, Australia all the treated lesions, 81 were basal cell carcinoma (49.2%), 65 cutaneous squamous cell carcinoma (39.4%), 7 lentigo maligna (LM) (4.2%), 2 sebaceous carcinoma (1.2%), 2 Correspondence: Prof Gerald Fogarty, Radiation Oncology, merkel cell carcinoma (1.2%), 4 Bowen’s disease (2.4%), 2 actinic change (1.2%) and 2 Mater Sydney, Crows Nest, NSW Australia, keloid treatments (1.2%). The mean follow-up was 42 weeks. Definitive RT, that is, RT Ph +61 2 9458 8050, Fax +61 2 9929 2687, given as primary treatment rather than post operatively, was given in 108 cases.
[Show full text]